Sinotherapeutics Inc. (SHA:688247)

Sinotherapeutics Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 12, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	5,020	4,517	4,978	7,593	-	-
Market Cap Growth	25.63%	-9.25%	-34.45%	-	-	-
Enterprise Value	4,277	3,769	4,194	6,771	-	-
Last Close Price	11.18	10.02	10.86	16.48	-	-
PE Ratio	43.02	35.37	81.50	81.71	-	-
PS Ratio	9.78	8.83	16.60	30.67	-	-
PB Ratio	3.86	3.55	4.11	6.45	-	-
P/TBV Ratio	3.97	3.66	4.28	6.74	-	-
P/FCF Ratio	400.84	127.97	-	-	-	-
P/OCF Ratio	43.77	34.69	384.14	103.76	-	-
EV/Sales Ratio	8.33	7.37	13.99	27.35	-	-
EV/EBITDA Ratio	33.18	27.36	62.24	80.84	-	-
EV/EBIT Ratio	38.34	31.55	94.67	116.33	-	-
EV/FCF Ratio	341.49	106.79	-	-	-	-
Debt / Equity Ratio	0	0	0	0.00	0.01	-
Debt / EBITDA Ratio	0.00	0.00	0.00	0.02	0.04	-
Debt / FCF Ratio	0.00	0	-	-	0.03	-
Asset Turnover	0.37	0.36	0.22	0.23	0.39	0.51
Inventory Turnover	2.90	2.63	2.34	1.96	1.71	2.29
Quick Ratio	11.61	8.19	9.13	9.76	6.21	3.37
Current Ratio	13.28	9.46	10.49	10.59	6.91	3.83
Return on Equity (ROE)	9.48%	10.29%	5.12%	9.87%	21.29%	24.97%
Return on Assets (ROA)	4.97%	5.31%	2.06%	3.31%	7.41%	12.26%
Return on Capital (ROIC)	5.55%	6.01%	2.32%	3.85%	9.35%	15.53%
Return on Capital Employed (ROCE)	8.10%	8.80%	3.50%	4.70%	12.30%	20.60%
Earnings Yield	2.37%	2.83%	1.23%	1.22%	-	-
FCF Yield	0.25%	0.78%	-0.52%	-1.36%	-	-
Dividend Yield	0.45%	0.62%	0.38%	0.38%	-	-
Payout Ratio	23.37%	21.83%	46.02%	-	-	-
Buyback Yield / Dilution	1.96%	2.92%	-11.22%	-3.32%	-0.21%	-
Total Shareholder Return	2.41%	3.54%	-10.84%	-2.95%	-0.21%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.